Aceragen | Attività Correnti



Current Assets Cambiamento Data
Abbott USD 23.15B 503M 2025-03
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Amgen USD 26.93B 2.1B 2025-03
Biogen USD 7.63B 169.2M 2025-03
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Cipla INR 232.89B 23.43B 2025-03
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 106M 8.83M 2024-12
CSL USD 11.31B 540M 2024-12
Dynavax Technologies USD 815.97M 32.97M 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Grifols EUR 5.73B 404.28M 2024-12
Merck USD 35.5B 3.28B 2025-03
Pfizer USD 45.86B 4.5B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
X T L Biopharmaceuticals USD 1.34M 647K 2024-12



Aceragen Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.